Preferential star strand biogenesis of pre‐miR‐24‐2 targets PKC‐alpha and suppresses cell survival in MCF‐7 breast cancer cells
Abstract
microRNAs (miRNA) are regulators of cellular pathways and alterations of normal miRNA expression levels have been shown to increase tumorigenesis. miR‐24 has been demonstrated as having both tumor suppressive and oncogenic properties depending on cell context. Here, we demonstrate a possible role for pre‐miR‐24‐2 as a tumor suppressor in the MCF‐7 breast cancer cell line through the preferential processing of mature miR‐24‐2* over miR‐24. Specifically, we show that the ectopic expression of miR‐24‐2* in MCF‐7 breast cancer cells results in a suppression of cellular survival both in vivo and in vitro. Notably, the overexpression of miR‐24‐2* results in a dampening of cell survival through the targeted suppression of PKCα. In addition, a similar biological change is observed in vivo where MCF‐7 cells overexpressing pre‐miR‐24‐2 have decreased tumorigenicity and tumor incidence. Taken together our data demonstrate that when overexpressed biogenesis of the pre‐miR‐24‐2 favors miR‐24‐2* in the MCF‐7 breast cancer cell line and suggests a tumor suppressive role for miR‐24‐2* observed through the inhibition of PKCα‐mediated cellular survival. © 2013 Wiley Periodicals, Inc.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
miR-24-2* (5p) directly targets PKCα, a factor required for the survival of MCF-7 breast cancer cells.
“Here, miR‐24‐2* (5p) directly targets PKCα (protein kinase C), a factor that is required for the survival of MCF‐7 breast cancer cells (Martin et al., 2012; Weldon et al., 2005).”
From microRNA strand selection: Unwinding the rules (2021) · cites this paper as Martin et al., 2012
The miR-24-2* (5p) strand is upregulated in MCF-7 breast cancer cell lines compared to control mammary epithelial cells.
“The miR‐24‐2* (5p) strand is upregulated in MCF‐7 breast cancer cell lines compared to control mammary epithelial cells (Martin et al., 2012), (Table 1).”
From microRNA strand selection: Unwinding the rules (2021) · cites this paper as Martin et al., 2012
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
p16INK4a Translation Suppressed by miR-24
Lal, A., Kim, H. H., Abdelmohsen, K., Kuwano, Y., Pullmann, R., Srikantan, S., Subrahmanyam, R., Martindale, J. L., Yang, X., Ahmed, F., et al. (2008) · PLoS ONE · doi:10.1371/journal.pone.0001864 · Cited by 268 · see citing works
Flagged first, then by citations
Research works printed but not linked: 52
- [1]Visone R Croce CM miRNAs and Cancer The American Journal of Pathology 2009 174 4 1131 1138 19264914 PMC2671346
- [2]Croce CM Causes and consequences of microRNA dysregulation in cancer Nature Reviews 2009 10 704 714 PMC3467096 19763153
- [3]Garzon R Calin GA Croce CM microRNAs in Cancer Annual Rev Medicine 2009 60 167 179 19630570
- [4]Alvarez-Garcia I Miska EA microRNA functions in animal development and human disease Development 2005 132 21 4653 4662 16224045
- [5]Chhabra R Dubey R Saini N Cooperative and individualistic functions of the microRNAs in the miR-23a∼27a∼24-2 cluster and its implication in human disease Molecular Cancer 2010 9 232 20815877 PMC2940846
- [6]Zaidi SK Dowdy CR Winjnen AJ Lian JB Azra R Stein JL Croce CM Stein GS Altered Runx1 Subnuclear Targeting Enhances Myeloid Cell Proliferation and Blocks Differentiation by Activating a miR-24/MKP-7/ MAPK Network Cancer Research 2009 69 21 8249 8255 19826043 PMC2995702
- [7]Qin W Shi Y Zhao B Yao Chengguo Jin L Jiexian M Jin Y miR-24 Regulates Apoptosis by Targeting the Open Reading Frame (ORF) Region of FAF1 in Cancer Cells Plos One 2010 2 5 e9429 20195546 PMC2828487
- [8]Walker JC Harland RM microRNA-24a is required to repress apoptosis in the developing neural retina Genes and Development 2009 23 1046 1051 19372388 PMC2682950
- [9]Mishra PJ Song B Mishra PJ Wang Y Humeniuk R Banerjee D Merlino G Ju J Bertino JR mir-24 tumor suppressor activity is regulated independent of p53 and through a target site polymorphism PLOS ONE 2009 12 e8445 1 10 PMC2794546 20041160
- [11]Blenkiron C Goldstein LD Thorne NP Spiteri I Chin S Dunning MJ Barbosa-Morais NL Teschendorff AE Green AR Ellis IO Tavare S Caldas C Miska EA MicroRNA expression profiling of human breast cancer identifies new markers of tumor subtype Genome Biology 2007 8 10 R214.2 10.1186/gb-2007-8-10-r214 17922911 PMC2246288 · DOI
- [12]Mailot G Lacroix-Triki M Pierredon S Gratadou L Schmidt S Benes V Roche H Dalenc F Auboeuf D Millevoi S Vagner S Widespread estrogen-dependent repression of microRNAs involved in breast tumor cell growth Cancer Research 2009 69 21 8332 8340 19826037
- [13]Baffa R Fassan M Volinia S O'Hara B Liu CG Palazzo JP Gardiman M Rugge M Gomella LG Croce CM Rosenberg A MicroRNA expression profiling of human metastatic cancers identifies cancer gene targets Journal of Pathology 2009 219 214 221 19593777
- [14]Zhang H Su S Zhou Q Lu Y Differential expression profiles of microRNAs between breast cancer cells and mammary epithelial cells Chinese Journal of Cancer 2009 28 5 1 9 19624877
- [15]Newton AC Protein Kinase C: structure, function, and regulation Journal of Biological Chemistry 1995 270 48 28495 28498 7499357
- [16]Nakashima S Protein Kinase C alpha (PKCalpha): regulation and Biological function Journal of Biochemistry 2002 132 5 669 675 12417014
- [17]Kolch W Heidecker G Kochs G Hummel R Vahidi H Mischak H Finkenzeller G Marme D Rapp UR Protein kinase C-alpha activates RAF-1 by direct phosphorylation Nature 1993 364 249 252 8321321
- [18]Schonwasser DC Marais RM Marshall CJ Parker PJ Activation of the mitogen-activated protein kinase/extracellular signal-regulated kinase pathway by conventional, novel, and atypical protein kinase C isotypes Molecular and Cellular Biology 1998 18 2 790 798 9447975 PMC108790
- [19]Lahn M Kohler G Sundell K Su C Paterson BM Bumol TF Protein Kinase C alpha expression in breast and ovarian cancer Oncology 2004 67 1 1 10 15459489
- [20]Ways DK Kukoly CA deVente J Hooker JL Bryant WO Posekany KJ Fletcher DJ Cook PP Parker PJ MCF-7 breast cancer cells transfected with protein kinase C-alpha exhibit altered expression of other protein kinase C isoforms and display a more aggressive neoplastic phenotype Journal Clinical Investigation 1995 95 4 1906 1915 PMC295735 7706498
- [21]Gupta AK Galoforo SS Berns CM Martinez AA Corry PM Guan KL Lee YJ Elevated levels of ERK2 in human breast carcinoma MCF-7 cells transfected with protein kinase C alpha Cell Prolif 1996 29 12 655 663 9146728
- [22]Blobe GC Sachs CW Khan WA Fabbro D Stabel S Wetsel WC Obeid LM Fine RL Hannun YA Selective regulation of expression of protein kinase C (PKC) isoenzymes in multidrug-resistant MCF-7 cells Functional significance of enhanced expression of PKC alpha Journal Biol Chem 1993 268 1 658 664 8093247
- [23]Struckhoff AP Bittman R Burow ME Novel ceramide analogs as potential chemotherapeutic agents in breast cancer The Journal of pharmacology and experimental therapeutics 309 523 532 2004 14742741
- [24]Antoon JW White MD Slaughter EM Targeting NF-kB mediated breast cancer chemoresistance through selective inhibition of sphingosine kinase-2 Cancer biology & therapy 11 2011 PMC3084971 21307639
- [25]Rhodes L Antoon J Muir SE Elliot S Beckman B Effects of human mesenchymal stem cells on ER-positive human breast carcinoma cells mediated through ER-SDF-1/CXCR4 crosstalk Molecular Cancer 2010 9 295 21087507 PMC2998478
- [26]Schmittgen TD Zakrajsek BA Mills AG Gorn V Singer MJ Reed MW Quantitative reverse transcription-polymerase chain reaction to study mRNA decay: comparison of endpoint and real-time methods Analytical Biochemistry 2000 285 194 204 10.1006/abio.2000.4753 11017702 · DOI
- [27]Antoon JW Liu J Gestaut MM Burow ME Beckman BS Foroozesh M Design, synthesis, and biological activity of a family of novel ceramide analogues in chemoresistant breast cancer cells J Med Chem 2009 52 18 5748 52 19694470
- [28]Antoon JW White MD Meacham WD Slaughter EM Muir SE Elliott S Rhodes LV Ashe HB Weise TE Smith CD Burow ME Beckman BS Antiestrogenic effects of the novel sphingosine kinase-2 inhibitor ABC294640 Endocrinology 2010 151 11 5124 35 20861237 PMC2954724
- [29]Zhou C Nitschke AM Xiong W Zhang Q Tang Y Bloch M Elliott S Zhu Y Bazzone L Yu D Weldon CB Schiff R McLachlan JA Beckman BS Wiese TE Nephew KP Shan B Burow ME Wang G Proteomic analysis of tumor necrosis factor-alpha resistant human breast cancer cells reveals a MEK5/Erk5-mediated epithelial-mesenchymal transition phenotype Breast Cancer Res 2008 10 R105 19087274 PMC2656902
- [30]Lal A Navarro F Maher C Maliszewski LE Yan N O'Day E Chowdhury D Dykxhoorn DM Tsai P Hofmann O Becker KG Gorospe M Lieberman J miR-24 inhibits cell proliferation by targeting E2F2, MYC, and other cell-cycle genes via binding to “seedless” 3′UTR microRNA recognition elements Molecular Cell 2009 35 5 610 625 19748357 PMC2757794
- [31]Nishizuka Y The role of protein kinase C in cell surface signal transduction and tumour promotion Nature 1984 308 5961 693 698 6232463
- [32]Vetter M Blumenthal SG Lindemann RK Manns J Wesselborg S Thomssen C Dittmer J Ets 1 is an Effector of Protein Kinase C alpha in Cancer Cells Oncogene 2005 24 4 650 661 15531915
- [33]Burow Me Weldon CB Collins-Burow BM Ramsey N Mckee A Klippel A McLachlan JA Vlejan S Beckman BS Cross-talk between phosphatidylinositol 3-kinase and sphingomyelinase pathways as a mechanism for cell survival/death decisions J Biol Chem 2000 275 13 9628 9635 10734114
- [34]Weldon CB McKee A Collins-Burow BM Melnik LI Scandurro AB McLachlan JA Burow ME Beckman BS PKC-mediated survival signaling in breast carcinoma cells: A role for MEK1-AP1 signaling International Journal of Oncology 2005 26 763 768 15703835
- [35]Kozomara A Griffiths-Jones S miRBase: integrating microRNA annotation and deep-sequencing data NAR 2011 39 Database Issue D152 D157 21037258 PMC3013655
- [36]Witten D Tibshirani R Gu SG Fire A Lui WO Ultra-high throughput sequencing-based small RNA discovery and discrete statistical biomarker analysis in a collection of cervical tumours and matched controls BMC Biol 8 58 2010 20459774 PMC2880020
- [37]Stark MS Tyagi S Nancarrow DJ Boyle GM Cook AL Whiteman DC Characterization of the Melanoma miRNAome by Deep Sequencing PLoS One 2010 5 e9685 20300190 PMC2837346
- [38]Zhu JY Pfuhl T Motsch N Barth S Nicholls J Grasser F Identification of novel Epstein-Barr virus microRNA genes from nasopharyngeal carcinomas J Virol 2009 83 3333 3341 19144710 PMC2655542
- [39]Bar M Wyman SK Fritz BR Qi J Garg KS Parkin RK MicroRNA discovery and profiling in human embryonic stem cells by deep sequencing of small RNA libraries Stem Cells 2008 26 2496 2505 18583537 PMC2847579
- [40]Rhead B Karolchik D Kuhn RM Hinrichs AS Zweig AS Fujita PA Diekhans M Smith KE Rosenbloom KR Raney BJ Pohl A Pheasant M Meyer LR Learned K Hsu F Hillman-Jackson J Harte RA Giardine B Dreszer TR Clawson H Barber GP Haussler D Kent WJ The UCSC Genome Browser database: update 2010 Nucleic Acids Research 2010 38 database issue D613 9 19906737 PMC2808870
- [41]Wang ET Sandberg R Luo S Khrebtukova I Zhang L Mayr C Kingsmore SF Schroth GP Burge CB Alternative isoform regulation in human tissue transcriptomes Nature 2008 456 470 476 18978772 PMC2593745
- [42]Xu G Fewell C Taylor C Deng N Hedges D Zhang K Lacey M Zhang H Yin Q Cameron J Lin Z Zhu D Flemigton EK Transcriptome and targetome analysis in MIR155 expressing cells using RNA-seq RNA 2010 16 1610 1622 20584899 PMC2905759
- [43]Deng N Puetter A Zhang K Johnson K Zhao Z Taylor C Flemington EK Zhu D Isoform-level microRNA-155 target prediction using RNA-seq Nucleic Acids Research 2011 39 9 e61 10.1093/nar/gkr042 21317189 PMC3089486 · DOI
- [45]Srivastava N Manvati S Srivastava A Pal R Kalaiarasan P Shilpi C miR-24-2 controls H2AFX expression regardless of gene copy number alteration and induces apoptosis by targeting antiapoptotic gene BCL2: a potential for therapeutic intervention Breast Cancer Research 2011 13 R39 21463514 PMC3219202
- [46]Park J Tian Y Simanshu D Chang H Jee D Patel D Dicer recognizes the 5′ end of RNA for efficient and accurate processing Nature 2011 475 201 207 21753850 PMC4693635
- [47]Starega-Roslan J Koscianska E Kozlowski P Krzyzosiak W The role of the precursor structure in the biogenesis of microRNA Cell Mol 2011 68 2859 2871 PMC3155042 21607569
- [48]Winter J Jung S Keller S Gregory RI Diederichs S Many roads to maturity: microRNA biogenesis pathways and their regulation Nature Cell Biology 2009 11 228 234 19255566
- [49]Khvorova A Reynolds A Jayasena SD Functional siRNA and miRNA exhibit strand bias Cell 2003 115 2 209 216 14567918
- [50]Yamagata K Fujiyama S Ito S Ueda T Murata T Naitou M Maturation of microRNA is hormonally regulated by a nuclear receptor Molecular Cell 2009 36 340 347 19854141
- [51]Paris O Ferraro L Grober O Ravo M Filippo M Giurato G Direct regulation of microRNA biogenesis and expression by estrogen receptor beta in hormone-responsive breast cancer Oncogene 2012 1 11 22231442
- [52]Hu H Yan Z Xu Y Hu H Menzel C Zhou Y Sequence features associated with microRNA strand selection in humans and flies BMC Genomics 2009 10 413 19732433 PMC2751786
- [53]Siomi H Siomi M Posttranscriptional regulation of microRNA biogenesis in animals Molecular Cell 2010 38 323 332 20471939
- [54]Takagi S Nakajima M Kida K Yamaura Y Fukami T Yokoi T MicroRNAs regulate human hepaotcyte nuclear factor 4alpha, modulating the expression of metabolic enzymes and cell cycle Journal of Biological Chemistry 2010 285 7 4415 4422 20018894 PMC2836046
Cited by
Sorted by citations
microRNA strand selection: Unwinding the rules
Medley, J. C., Panzade, G., & Zinovyeva, A. Y. (2021) · WIREs RNA · doi:10.1002/wrna.1627 · Cited by 225 · see citing works
- Authors
- Martin, E. C., Elliott, S., Rhodes, L. V., Antoon, J. W., Fewell, C., Zhu, Y., Driver, J. L., Jodari‐Karimi, M., Taylor, C. W., Flemington, E. K., Beckman, B. S., Collins‐Burow, B. M., & Burow, M. E.
- Affiliations
- Department of Medicine Section of Hematology and Medical Oncology Tulane University New Orleans Louisiaina
- Department of Pharmacology Tulane University New Orleans Louisiaina
- Department of Pathology Tulane University New Orleans Louisiaina
- Department of Computer Science University of New Orleans New Orleans Louisiaina
- Venue
- Molecular Carcinogenesis
- Publisher
- Wiley
- Published
- 2012-08-21
- Volume
- 53
- Issue
- 1
- Pages
- 38-48
- ISSN
- 0899-1987
- 1098-2744
- PMC
- PMC4030540
- Cited by
- 43
- References
- 1
- Language
- en
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review